The prevalence and disease course of autoimmune liver diseases in Greenland
- PMID: 38465864
- PMCID: PMC10930088
- DOI: 10.1080/22423982.2024.2327693
The prevalence and disease course of autoimmune liver diseases in Greenland
Abstract
Autoimmune liver diseases are rare serious diseases causing chronic inflammation and fibrosis in the liver parenchyma and bile ducts. Yet, the prevalence and burden of autoimmune liver diseases are largely unexplored in Arctic native populations. We investigated the prevalence and management of autoimmune liver diseases in Greenland using nationwide cross-sectional register data and subsequent medical chart reviews validating diagnoses and extracting liver histology examinations and medical treatments. The overall prevalence of autoimmune liver diseases in Greenland was 24.6 per 100,000 (95% CI: 14.7-41.3). This was based on 7 patients with autoimmune hepatitis (AIH) (12.3 per 100,000), 3 patients with primary biliary cholangitis (PBC) (5.3 per 100,000), 4 patients with AIH/PBC overlap disease (7.0 per 100,000), and no patients with primary sclerosing cholangitis. All diagnoses were confirmed by liver histology examinations. Medical treatments adhered to internal recommendations and induced complete remission in most patients with AIH, and complete or partial remission in 1 patient with PBC and 3 patients with AIH/PBC overlap disease. One patient had established cirrhosis at the time of diagnosis, while 2 patients progressed to cirrhosis. In conclusion, the prevalence of autoimmune liver diseases was lower in Greenland than in Scandinavia and among Alaska Inuit.
Keywords: Arctic; Greenland; Inuit; autoimmune hepatitis; autoimmune liver disease; primary biliary cholangitis; primary sclerosing cholangitis.
Conflict of interest statement
Henning Grønbæk reports: Research grants (AbbVie, Intercept, ARLA Food for Health, ADS AIPHIA Development Services AG); Consulting Fees (Ipsen, NOVO, Pfizer); Lecturer (AstraZeneca, EISAI); Data Monitoring Committee (CAMURUS AB).
The other authors report there are no competing interests to declare.
Similar articles
-
[Autoimmune liver diseases and their overlap syndromes].Praxis (Bern 1994). 2006 Sep 6;95(36):1363-81. doi: 10.1024/1661-8157.95.36.1363. Praxis (Bern 1994). 2006. PMID: 16989180 Review. German.
-
Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.Scand J Gastroenterol. 1998 Jan;33(1):99-103. doi: 10.1080/00365529850166284. Scand J Gastroenterol. 1998. PMID: 9489916
-
Diagnosis and management of overlap syndromes.Clin Liver Dis. 2015 Feb;19(1):81-97. doi: 10.1016/j.cld.2014.09.005. Epub 2014 Nov 21. Clin Liver Dis. 2015. PMID: 25454298 Review.
-
Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.Clin Gastroenterol Hepatol. 2018 Feb;16(2):278-287.e7. doi: 10.1016/j.cgh.2017.09.062. Epub 2017 Oct 6. Clin Gastroenterol Hepatol. 2018. PMID: 28993258
-
Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.BMC Gastroenterol. 2024 Jan 4;24(1):17. doi: 10.1186/s12876-023-03105-7. BMC Gastroenterol. 2024. PMID: 38178070 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical